Department of Cardiac Surgery, University of Michigan Cardiovascular Center, Ann Arbor, Michigan 48109-5864, USA.
Ann Thorac Surg. 2013 Jul;96(1):23-30; discussion 230. doi: 10.1016/j.athoracsur.2013.01.041. Epub 2013 Mar 8.
Aortic repair for acute (<2 weeks) or subacute (2 to 8 weeks) type B dissection is performed for rupture, impending rupture, or malperfusion. Thoracic aortic endovascular repair (TEVAR) has been suggested as a more suitable, less invasive alternative to open descending aortic repair for type B dissection, but a comparative analysis is warranted.
Seventy-three patients with type B dissection (1995 to 2012) underwent early open descending aortic repair (n = 24) or TEVAR (n = 49). Mean age was 66.3 years. Intervention occurred in the acute (n = 53) or subacute (n = 20) period for malperfusion (n = 8), rupture (n = 22), or factors portending rupture, including rapid expansion (n = 26), uncontrolled pain (n = 18), aortic size greater than 5.0 cm (n = 26), or refractory hypertension (n = 2). Twenty-six had multiple indications. Patients undergoing TEVAR were older and had an increased incidence of coronary artery disease and renal impairment (all p < 0.05).
Thirty-day mortality was 12% (n = 9). Morbidity included stroke (n = 7), dialysis (n = 6), paralysis (n = 4), and tracheostomy (n = 7). A composite outcome of mortality and these morbidities independently correlated with presentation with frank rupture (p < 0.01) or limb ischemia (p = 0.03), but not treatment strategy (p = 0.3). Ten-year Kaplan-Meier survival was 57.5% and similar between groups (p = 0.74). Independent predictors of late mortality included perioperative stroke and presentation with rupture during late follow-up (both p < 0.02). Five-year freedom from aortic reintervention or rupture was similar between TEVAR (80.0%) and open descending aortic repair (82.8%; p = 0.45).
Early aortic repair for complicated type B dissection is associated with high rates of morbidity, late mortality, and reintervention. Despite its use in a higher risk group, outcomes seen with TEVAR were similar to open repair, thus supporting the recent paradigm shift toward an endovascular approach.
对于急性(<2 周)或亚急性(2 至 8 周)B 型夹层,进行主动脉修复是为了预防破裂、即将破裂或灌注不良。胸主动脉腔内修复术(TEVAR)已被认为是一种更合适、侵入性更小的替代开放性降主动脉修复术的方法,适用于 B 型夹层,但需要进行对比分析。
73 例 B 型夹层患者(1995 年至 2012 年)接受了早期开放性降主动脉修复术(n=24)或 TEVAR(n=49)。平均年龄为 66.3 岁。干预发生在急性(n=53)或亚急性(n=20)期间,原因包括灌注不良(n=8)、破裂(n=22)或预示破裂的因素,包括快速扩张(n=26)、无法控制的疼痛(n=18)、主动脉直径大于 5.0cm(n=26)或难治性高血压(n=2)。26 例患者有多种适应证。行 TEVAR 的患者年龄较大,且更常伴有冠状动脉疾病和肾功能不全(均 p<0.05)。
30 天死亡率为 12%(n=9)。发病率包括卒中(n=7)、透析(n=6)、瘫痪(n=4)和气管切开术(n=7)。死亡率和这些并发症的复合结果与破裂(p<0.01)或肢体缺血(p=0.03)的临床表现独立相关,但与治疗策略无关(p=0.3)。10 年 Kaplan-Meier 生存率为 57.5%,两组间无差异(p=0.74)。晚期死亡率的独立预测因素包括围手术期卒中以及晚期随访时出现破裂(均 p<0.02)。TEVAR(80.0%)和开放性降主动脉修复(82.8%;p=0.45)的 5 年免于主动脉再次介入或破裂的比例相似。
复杂 B 型夹层的早期主动脉修复与较高的发病率、晚期死亡率和再次干预有关。尽管 TEVAR 用于风险较高的患者,但结果与开放性修复相似,这支持了最近向腔内治疗方法转变的观点。